Metraipolis › archive › dc_889b87be482f

Tumour microenvironment and HER2-low status dictate response and resistance to anthracycline-taxane chemotherapy in premenopausal TNBC: a retrospective… — Europe PMC PMID:41737551

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41737551
DOI
10.3389/fphar.2026.1752328
License (as archived)
solo-consultazione
Archived
2026-11-06T00:43:25.314Z
SHA-256 of the archived text
7583d72c74f34b21f7d7fbafd56909fd14f385ed282704cb6e7e0fef6d09f737
Stable URL of this page
https://metraipolis.com/documento/dc_889b87be482f

How to cite

Tumour microenvironment and HER2-low status dictate response and resistance to anthracycline-taxane chemotherapy in premenopausal TNBC: a retrospective… — Europe PMC PMID:41737551 — Europe PMC (en), https://europepmc.org/article/MED/41737551 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_889b87be482f (Metraipolis archive dc_889b87be482f, sha256 7583d72c74f34b21f7d7fbafd56909fd14f385ed282704cb6e7e0fef6d09f737)
BibTeX
@misc{dc889b87be482f,
  title = {Tumour microenvironment and HER2-low status dictate response and resistance to anthracycline-taxane chemotherapy in premenopausal TNBC: a retrospective… — Europe PMC PMID:41737551},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41737551},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_889b87be482f; sha256 7583d72c74f34b21f7d7fbafd56909fd14f385ed282704cb6e7e0fef6d09f737},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41737551. Agents can read the archived copy with the MCP tool read_document.